Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Canadian approval for Depo-Provera

April 10, 1997

Amgen obtains additional EPO patent protection

April 10, 1997

Roussel Uclaf transfers all rights and responsibilities related to mifepristone to Dr. Sakiz

April 10, 1997

GelTex issued U.S. patent for cholesterol-reducing polymers

April 10, 1997

Ergoset enters clinical trials as adjunct therapy for type II diabetes

April 10, 1997

Lilly describes agents for postmenopausal syndrome

April 9, 1997

Chronic MK-677 increases GH and IGF-I in dogs

April 8, 1997

Cobalt porphyrins for obesity from Warner-Lambert

April 8, 1997

NO-1886 increases HDL cholesterol by increasing LPL activity

April 7, 1997

Nonoxynol-9 not effective for reducing HIV transmission

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...